ARCHIVES

Rituximab Prolonged Survival Of CLL In Phase III Study

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions

November 11, 1977

Cancer Control RFA Announcements

March 9, 1979

Clinical Trials Approved By NCI Listed For September

September 24, 2004

Bass & Howes Bought By DDB Seattle

March 22, 2002

In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel

June 4, 1999

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980